1. Home
  2. MNKD vs PDO Comparison

MNKD vs PDO Comparison

Compare MNKD & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • PDO
  • Stock Information
  • Founded
  • MNKD 1991
  • PDO 2020
  • Country
  • MNKD United States
  • PDO United States
  • Employees
  • MNKD N/A
  • PDO N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • PDO Trusts Except Educational Religious and Charitable
  • Sector
  • MNKD Health Care
  • PDO Finance
  • Exchange
  • MNKD Nasdaq
  • PDO Nasdaq
  • Market Cap
  • MNKD 1.7B
  • PDO 1.7B
  • IPO Year
  • MNKD 2004
  • PDO N/A
  • Fundamental
  • Price
  • MNKD $5.72
  • PDO $14.20
  • Analyst Decision
  • MNKD Strong Buy
  • PDO
  • Analyst Count
  • MNKD 5
  • PDO 0
  • Target Price
  • MNKD $10.80
  • PDO N/A
  • AVG Volume (30 Days)
  • MNKD 3.8M
  • PDO 520.0K
  • Earning Date
  • MNKD 11-06-2025
  • PDO 01-01-0001
  • Dividend Yield
  • MNKD N/A
  • PDO 11.80%
  • EPS Growth
  • MNKD 149.32
  • PDO N/A
  • EPS
  • MNKD 0.11
  • PDO N/A
  • Revenue
  • MNKD $301,736,000.00
  • PDO N/A
  • Revenue This Year
  • MNKD $16.36
  • PDO N/A
  • Revenue Next Year
  • MNKD $20.34
  • PDO N/A
  • P/E Ratio
  • MNKD $52.68
  • PDO N/A
  • Revenue Growth
  • MNKD 21.48
  • PDO N/A
  • 52 Week Low
  • MNKD $3.38
  • PDO $10.65
  • 52 Week High
  • MNKD $7.63
  • PDO $13.31
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 63.58
  • PDO 77.85
  • Support Level
  • MNKD $5.33
  • PDO $14.06
  • Resistance Level
  • MNKD $5.90
  • PDO $14.02
  • Average True Range (ATR)
  • MNKD 0.21
  • PDO 0.06
  • MACD
  • MNKD -0.02
  • PDO 0.01
  • Stochastic Oscillator
  • MNKD 77.46
  • PDO 94.91

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest

PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.

Share on Social Networks: